metformin has been researched along with Teratoma in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Teratoma: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vazquez-Martin, A | 1 |
| Cufi, S | 1 |
| Lopez-Bonet, E | 1 |
| Corominas-Faja, B | 1 |
| Oliveras-Ferraros, C | 1 |
| Martin-Castillo, B | 1 |
| Menendez, JA | 1 |
1 other study available for metformin and Teratoma
| Article | Year |
|---|---|
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency.
Topics: Animals; Cell Differentiation; Cell Line; Cell Transformation, Neoplastic; Hypoglycemic Agents; Indu | 2012 |